Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696981 · ClinicalTrials.gov registry record · NA
Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)
A NA study of Colon Carcinoma and Rectal Carcinoma, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- NA
- Development phase
- 154,900
- Enrollment target
- 1
- Study location
NCT01696981 is a NA study of Colon Carcinoma and Rectal Carcinoma that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 154,900 participants, above the 968-participant average among 7 other Colon Carcinoma trials with a reported enrollment target (15902% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01696981, a NA study of Colon Carcinoma and Rectal Carcinoma, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 154,900 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for colorectal cancer.
Conditions Studied
Interventions
- OTHER Screening Questionnaire Administration
- PROCEDURE Sigmoidoscopy
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154,900 participants |
| Start Date | 1993-11-16 |
| Est. Completion | 2026-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01696981
The ClinicalTrials.gov registry entry for NCT01696981 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 154,900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 968-participant average among 7 other Colon Carcinoma trials with a reported enrollment target (15902% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colon Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Screening Questionnaire Administration is the first listed.
NCT01696981 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01696981 about?
NCT01696981 is a clinical study titled "Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)". This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for colorectal cancer.
What is the current status of trial NCT01696981?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 154,900 participants. The study started on 1993-11-16. Estimated completion is 2026-03-25.
What conditions does trial NCT01696981 study?
This clinical trial studies the following conditions: Colon Carcinoma, Rectal Carcinoma.
What interventions are being tested in trial NCT01696981?
The interventions under investigation include: Screening Questionnaire Administration (OTHER), Sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01696981?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696981 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques
ACTIVE NOT RECRUITING · NA
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
COMPLETED · NA
-
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
RECRUITING · Phase 2
-
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
ACTIVE NOT RECRUITING · Phase 1
-
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
ACTIVE NOT RECRUITING · Phase 2
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.